CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ADVANCE-AD aims to enhance the diagnosis and treatment of Alzheimer's disease by developing innovative blood-based biomarkers. The project focuses on early detection and intervention strategies to improve patient outcomes and expedite the evaluation of new therapies.
Alzheimer’s disease (AD) is the most common cause of dementia and a major global health challenge. AD has a long pre-symptomatic phase spanning several decades.
The accuracy of clinical AD diagnostics is mediocre, especially in primary care.
This results in suboptimal treatment and care, which is especially problematic in light of emerging anti-amyloid therapies. ADVANCE-AD aims to revolutionize AD diagnostics and prognostics and fast-track the development of new effective therapies by using nov…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
